34.11 +0.06 (0.18%)
PFE
| Trade PFE now with |
Stock Details
Last Trade:34.11 Change:+0.06 (0.18%) Prev Close:34.05 Open: 34.14 Days Range:34.00 – 34.32 52 Week Range: 28.25 - 37.39 Volume:19179038 P/E: 20.67EPS:1.65
View AllRecent Alerts 03/11/17
Recent Alert on 03/09/17 at 6:29am
Servier, Pfizer (PFE) Announce FDA Clearance of IND Application for UCART19 for B-ALL (CLLS)
Servier, Pfizer (PFE) Announce FDA Clearance of IND Application for UCART19 for B-ALL (CLLS)
Servier, together with Pfizer Inc. (NYSE:PFE) and Cellectis (NASDAQ:CLLS), announced today that the U.S. Food and Drug Administration (FDA) has granted Servier with an Investigational New Drug (IND) clearance to proceed in the U.S. with the clinical... Read More
Recent Alert on 03/06/17 at 8:34am
Bristol-Myers Squibb (BMY), Pfizer (PFE) to Present New Analyses of Eliquis and Real-World Data at ACC
Bristol-Myers Squibb (BMY), Pfizer (PFE) to Present New Analyses of Eliquis and Real-World Data at ACC
Recent Alert on 03/06/17 at 8:02am
Merck (MRK), Pfizer (PFE) Announce FDA and EMA Filing Acceptances of Three Marketing Applications for Ertugliflozin-Containing Medicines
Merck (MRK), Pfizer (PFE) Announce FDA and EMA Filing Acceptances of Three Marketing Applications for Ertugliflozin-Containing Medicines
View AllRecent Press Releases
Press Release on 03/09/17 at 2:00am
Servier and Pfizer Announce FDA Clearance of IND Application for UCART19 in Adult Relapsed/Refractory Acute Lymphoblastic Leukemia
Servier and Pfizer Announce FDA Clearance of IND Application for UCART19 in Adult Relapsed/Refractory Acute Lymphoblastic Leukemia
Press Release on 03/08/17 at 10:00am
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
View AllRecent SEC Filings
View AllRecent Blog Posts
Blog Posts on 08/06/13 at 10:08am
Senesco's Extreme Undervaluation Provides Multi-Bagger Opportunity
Senesco's Extreme Undervaluation Provides Multi-Bagger Opportunity
Blog Posts on 08/06/13 at 9:28am
Antares Pharma's Otrexup Will Gain FDA Approval And Generate Positive EPS
Antares Pharma's Otrexup Will Gain FDA Approval And Generate Positive EPS